"...This combination is tailored for patients whos
Post# of 148087
https://www.targetedonc.com/view/fda-clears-p...stable-crc
Sorry if already discussed. Does this tailoring insure that those genetically inappropriate to the goals are excluded so as not to dilute efficacy? TIA.